RG6351
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2025
THAMES: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
(clinicaltrials.gov)
- P1/2 | N=546 | Recruiting | Sponsor: Genentech, Inc.
New P1/2 trial • Diabetic Macular Edema • Ophthalmology
1 to 1
Of
1
Go to page
1